Zhang Xingqi, Li Zequn, Sun Yuqi, Liu Gan, Liu Xiaodong, Zhou Yanbing
Department of Gastrointestinal Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
Cancer Manag Res. 2021 May 18;13:4055-4065. doi: 10.2147/CMAR.S297451. eCollection 2021.
The present study aimed to examine the association of tumour necrosis factor-α-induced protein 8 (TIPE) expression levels with clinicopathological features and prognosis of patients with colon cancer following surgery.
The present study included 200 patients with colon cancer who underwent colon resection between June 2011 and October 2012. All follow-ups were censored in July 2020, with a median follow-up time of 62.25 months. Kaplan-Meier survival curve analysis and Cox regression analysis were used to determine predictors for the overall survival rate.
High expression of TIPE was associated with lymph node metastasis, higher Dukes' stage and right-sided colon cancer (RCC). An exploratory subgroup analysis found that high expression of TIPE was associated with age ≥65, lymphatic invasion and higher Dukes' stage only in the RCC group (<0.05), whereas no similar trend was observed in the left-sided colon cancer (LCC) subgroup. Age ≥65, differentiation, lymph node metastasis and TIPE expression levels were independent prognostic factors influencing the survival rate of patients with colon cancer following surgery in multivariate Cox analysis (<0.05). ROC curve analysis showed that the immunoreactive score of TIPE had good predictive value for five-year survival rates (AUC=0.727) and lymph node metastasis (AUC=0.760) among patients with RCC. Survival analysis revealed that the expression of TIPE had a significant impact on survival, and higher expression levels suggested a worse prognosis.
This study demonstrated that TIPE may be a novel biomarker for predicting the survival outcome and lymph node metastasis. TIPE was overexpressed in colon cancer tissue and significantly associated with poor patient survival, especially in patients with RCC.
本研究旨在探讨肿瘤坏死因子-α诱导蛋白8(TIPE)表达水平与结肠癌患者术后临床病理特征及预后的相关性。
本研究纳入了2011年6月至2012年10月期间接受结肠切除术的200例结肠癌患者。所有随访均于2020年7月结束,中位随访时间为62.25个月。采用Kaplan-Meier生存曲线分析和Cox回归分析来确定总生存率的预测因素。
TIPE高表达与淋巴结转移、较高的Dukes分期及右半结肠癌(RCC)相关。探索性亚组分析发现,仅在RCC组中,TIPE高表达与年龄≥65岁、淋巴管侵犯及较高的Dukes分期相关(<0.05),而在左半结肠癌(LCC)亚组中未观察到类似趋势。在多因素Cox分析中,年龄≥65岁、分化程度、淋巴结转移及TIPE表达水平是影响结肠癌患者术后生存率的独立预后因素(<0.05)。ROC曲线分析显示,TIPE免疫反应评分对RCC患者的五年生存率(AUC=0.727)和淋巴结转移(AUC=0.760)具有良好的预测价值。生存分析显示,TIPE的表达对生存有显著影响,较高的表达水平提示预后较差。
本研究表明,TIPE可能是预测生存结局和淋巴结转移的新型生物标志物。TIPE在结肠癌组织中过表达,与患者不良生存显著相关,尤其是在RCC患者中。